PsiThera
Latest round
- Series A
Last raised
- Dec 2025
Total raised
- $48M
Investors
- 5
About PsiThera
Founded in 2022 and headquartered in Watertown, US, PsiThera, Inc. focuses on creating oral therapeutics targeting immunological conditions.PsiThera specializes in the development of innovative oral small molecules targeting high-value immunology and inflammatory disease areas that have traditionally relied on injected biologics. Central to their offerings is the QUAISAR platform, which models biologically relevant protein motion to identify hidden druggable states often overlooked by conventional drug discovery. This platform enables the design of therapeutics aimed at specific targets within the tumor necrosis factor (TNF) superfamily and other validated immunological targets.PsiThera's revenue model is built around partnerships and collaborations within the biopharmaceutical sector, focusing on delivering its proprietary drug candidates to pharmaceutical companies and healthcare providers. Transactions typically occur through licensing agreements, where PsiThera grants rights to its technologies and products in exchange for upfront payments and royalties on future sales. Flagship products developed through the QUAISAR platform are expected to drive these agreements, as they aim to introduce the first oral therapies in their respective categories.PsiThera, Inc.50 mn to support the design and launch of new oral therapies. The company is focused on expanding its presence into new markets in Europe and Asia by 2025.
Who invested in PsiThera
5 investors across 1 round
See all investors in PsiThera
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Dec 10, 2025
Amount
$48M
Investors
Questions about PsiThera
Who invested in PsiThera?
PsiThera has 5 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has PsiThera raised?
PsiThera has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did PsiThera last raise money?
PsiThera's most recent round on record is a Series A, in Dec 2025.
What does PsiThera do?
Founded in 2022 and headquartered in Watertown, US, PsiThera, Inc.
Where is PsiThera headquartered?
PsiThera is headquartered in Watertown, US.
Which VCs invest in companies like PsiThera?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at PsiThera's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like PsiThera? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.